The vaccine, called Ervebo, is the first such drug to gain FDA approval in the United States. Ervebo was approved by the European Commission in November.
In a study conducted in West Africa during the 2014-16 Ebola outbreak, the vaccine was found to be 100 percent effective in preventing the deadly disease.
“While the risk of Ebola virus disease in the U.S. remains low, the U.S. government remains deeply committed to fighting devastating Ebola outbreaks in Africa, including the current outbreak in the Democratic Republic of the Congo,” Anna Abram, the FDA's deputy commissioner for policy, legislation and international affairs, said in a statement Thursday.
Read the full story on NBCNews.com